Literature DB >> 15147964

Biodistribution of intracellularly acting peptides conjugated reversibly to Tat.

Rebecca Begley1, Tamar Liron, Jeremy Baryza, Daria Mochly-Rosen.   

Abstract

Intracellularly acting peptide modulators of signaling enzymes provide a powerful means to regulate signaling events. Delivery of peptides into cells is facilitated by conjugation to carrier peptides, such as Tat. When peptides are irreversibly conjugated to Tat, Tat-mediated subcellular localization may predominate, resulting in mislocalization of the peptide cargo. We have used intracellularly acting peptides, conjugated to Tat by a disulfide bond, to modulate protein kinase C (PKC) signaling; these PKC-modulating peptides are released from Tat upon intracellular delivery. Previously, the distribution of these peptides within tissue and throughout the body had not been demonstrated. We show here intravascular delivery of a PKC-peptide, reversibly conjugated to Tat, resulted in distribution throughout cardiac tissue. In addition, a single injection resulted in selective modulation of PKC activity in many organs. Therefore, intracellularly acting peptide modulators of signaling enzymes, reversibly conjugated to Tat, have extensive biodistribution and can be used to modulate signaling pathways in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147964     DOI: 10.1016/j.bbrc.2004.04.121

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-δ (δ-PKC).

Authors:  Laurie E Kilpatrick; Stephen W Standage; Haiying Li; Nichelle R Raj; Helen M Korchak; Marla R Wolfson; Clifford S Deutschman
Journal:  J Leukoc Biol       Date:  2010-08-19       Impact factor: 4.962

2.  Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cells.

Authors:  Vidya Mamidipudi; Laura D Miller; Daria Mochly-Rosen; Christine A Cartwright
Journal:  Biochem Biophys Res Commun       Date:  2006-11-15       Impact factor: 3.575

3.  Rational design of a selective antagonist of epsilon protein kinase C derived from the selective allosteric agonist, pseudo-RACK peptide.

Authors:  Tamar Liron; Leon E Chen; Hanita Khaner; Alice Vallentin; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2007-01-24       Impact factor: 5.000

Review 4.  Rationally designed peptide regulators of protein kinase C.

Authors:  Eric N Churchill; Nir Qvit; Daria Mochly-Rosen
Journal:  Trends Endocrinol Metab       Date:  2008-12-04       Impact factor: 12.015

5.  Pulmonary endothelial protein kinase C-delta (PKCδ) regulates neutrophil migration in acute lung inflammation.

Authors:  Mark J Mondrinos; Ting Zhang; Shuang Sun; Paul A Kennedy; Devon J King; Marla R Wolfson; Linda C Knight; Rosario Scalia; Laurie E Kilpatrick
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

6.  epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury.

Authors:  Rachel Bright; Guo-Hua Sun; Midori A Yenari; Gary K Steinberg; Daria Mochly-Rosen
Journal:  Neurosci Lett       Date:  2008-05-27       Impact factor: 3.046

7.  Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure.

Authors:  Suresh Selvaraj Palaniyandi; Koichi Inagaki; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2008-09-04       Impact factor: 5.000

8.  A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity.

Authors:  Xin Qi; Nir Qvit; Yu-Chin Su; Daria Mochly-Rosen
Journal:  J Cell Sci       Date:  2012-12-13       Impact factor: 5.285

9.  PKCε as a novel promoter of skeletal muscle differentiation and regeneration.

Authors:  D Di Marcantonio; D Galli; C Carubbi; G Gobbi; V Queirolo; S Martini; S Merighi; M Vaccarezza; N Maffulli; S M Sykes; M Vitale; P Mirandola
Journal:  Exp Cell Res       Date:  2015-09-30       Impact factor: 3.905

10.  Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury.

Authors:  Grant R Budas; Eric N Churchill; Marie-Hélène Disatnik; Lihan Sun; Daria Mochly-Rosen
Journal:  Cardiovasc Res       Date:  2010-06-16       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.